Literature DB >> 7572896

Simultaneous prolonged recordings of proximal and distal intraesophageal pH in children with gastroesophageal reflux disease and respiratory symptoms.

S Cucchiara1, F Santamaria, R Minella, E Alfieri, A Scoppa, F Calabrese, M T Franco, B Rea, G Salvia.   

Abstract

OBJECTIVES: To characterize both proximal and distal esophageal acid exposure in children with gastroesophageal reflux-related respiratory disease and to investigate the usefulness of dual-channel intraesophageal pH monitoring in these patients.
METHODS: Continuous simultaneous recording of distal and proximal esophageal pH was performed in 40 patients with gastroesophageal reflux disease and respiratory symptoms (wheezing, nocturnal cough, obstructive bronchitis) (age range 3-168 months) (group A), in 20 patients with reflux disease alone (age range 7-156 months) (group B), and in 14 controls (age range 5-108 months) (group C).
RESULTS: (expressed as median +/- SD) 1) The two groups of patients did not differ with regard to distal and proximal esophageal acid exposure (percentage of reflux) during both the total recording period [distal, A: 9.2 +/- 4, B: 10.7 +/- 7 (NS), C: 1.9 +/- 1.0; and proximal, A: 4.8 +/- 3.3, B: 4.0 +/- 3.3 (NS), C: 1.0 +/- 0.7] and during nighttime [distal, A: 8.0 +/- 6.2, B: 10.4 +/- 6.1 (NS), C: 0.9 +/- 0.65; and proximal, A: 3.72 +/- 3, B: 3.6 +/- 3.0 (NS), C: 0.75 +/- 0.45]. 2) The two groups did not differ with regard to the ratio between proximal and distal esophageal acid exposure during both total and nocturnal periods of analysis. 3) No significant correlation was found between distal and proximal esophageal acid exposure during total and nocturnal recording periods. 4) In patients with reflux-related respiratory disease, the respiratory symptomatic index was significantly higher during distal esophageal acid exposure alone (47.0 +/- 28.6%) than during simultaneous reflux at the two esophageal levels (26.9 +/- 27%) (p < 0.05). Furthermore, reflux episodes associated with respiratory symptoms reached lower pH values than those in patients without symptoms at the two recording sites.
CONCLUSIONS: Gastroesophageal reflux into the proximal esophagus does not discriminate between patients with reflux disease alone and those with reflux disease complicated by respiratory symptoms. Symptoms of asthma in reflux patients appear to be elicited more by a reflex mechanism than by aspiration of gastric refluxate into the airways. Intraesophageal acidification seems to be involved in eliciting respiratory symptoms related to reflux disease, and prolonged intraesophageal two-level pH measurement does not seem to be useful in the approach to patients with reflux disease associated with respiratory symptoms.

Entities:  

Mesh:

Year:  1995        PMID: 7572896

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  5 in total

1.  Gastroesophageal reflux as cause of chronic respiratory symptoms.

Authors:  Hamid Reza Foroutan; Masomeh Ghafari
Journal:  Indian J Pediatr       Date:  2002-02       Impact factor: 1.967

Review 2.  Role of drug therapy in the treatment of gastro-oesophageal reflux disorder in children.

Authors:  S Cucchiara; M T Franco; G Terrin; R Spadaro; G di Nardo; V Iula
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.022

3.  24-hour esophageal pH-monitoring in children suspected of gastroesophageal reflux disease: analysis of intraesophageal pH monitoring values recorded in distal and proximal channel at diagnosis.

Authors:  Janusz Semeniuk; Maciej Kaczmarski
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

4.  Cough: are children really different to adults?

Authors:  Anne B Chang
Journal:  Cough       Date:  2005-09-20

5.  Evaluation of 563 children with chronic cough accompanied by a new clinical algorithm.

Authors:  Ahmet Hakan Gedik; Erkan Cakir; Emel Torun; Aysegul Dogan Demir; Mehmet Kucukkoc; Ufuk Erenberk; Selcuk Uzuner; Mustafa Nursoy; Emin Ozkaya; Fadlullah Aksoy; Selim Gokce; Kayhan Bahali
Journal:  Ital J Pediatr       Date:  2015-10-06       Impact factor: 2.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.